Omniox Stock

omniox.comHealthcareFounded: 2006Funding to Date: $87.65MM

Omniox is a provider of biotherapeutics for ischemic, hypoxic, and anemic diseases in oncology, cardiovascular and stroke diseases, diabetes, trauma, surgery, and sickle cell crises with a focused on overcoming biochemical shortcomings in prior efforts at oxygen and nitric oxide delivery.

Register for Details

For more details on financing and valuation for Omniox, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Omniox.

Register Today

Team

Management Team

Michael Marletta Ph.D
Co-Founder & Chairman
Stephen Cary Ph.D
Co-Founder, Chief Executive Officer & Board Member
Jonathan Winger Ph.D
Founder & Vice President, Process Development and New Product Introduction

Board Members

Jeffrey Samberg
Acadia Woods Partners
Ajit Shah Ph.D
Michael Marletta Ph.D
John Wesley

Other companies like Omniox in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$885.01MM